“REDEFINING ALZHEIMER’S DISEASE THROUGH MODERN BIOTECHNOLOGY; FROM MOLECULAR PATHOGENESIS TO INNOVATIVE THERAPEUTICS AND DIAGNOSTIC FRONTIERS”, JMHSR, vol. 2, no. 4, Dec. 2025, doi: 10.65035/w1y9ey43.